What Месакол treats: main uses and benefits

Месакол (Mesacol, a brand of mesalazine/mesalamine) is a medication used to help manage symptoms associated with specific inflammatory bowel conditions. It is primarily used to address inflammation in the digestive tract. The medicine is employed both for the short-term treatment of active disease and for the ongoing management of quiescent phases to support symptom relief.

The indications for this medication include the management of mild to moderate ulcerative colitis, as well as maintenance of remission in ulcerative colitis and certain forms of Crohn's ileo-colitis. It may help address disruptive symptoms that can accompany these conditions, such as diarrhea, stomach discomfort, and rectal bleeding. The overall benefit is assistance in achieving and sustaining periods of well-being where symptoms are managed.

The drug is primarily indicated to treat inflammatory bowel disease and is used for inducing or maintaining remission in mild-to-moderate cases of ulcerative colitis. This use is aligned with standard practice.

---

Quick Fact: Symptom Management

The medication is used to help manage inflammation and related symptoms associated with certain bowel conditions.

Regulatory References

1. https://www.ncbi.nlm.nih.gov/books/NBK551714/

Mesacol (mesalamine, or 5-aminosalicylic acid) is primarily prescribed for adults and children, typically five years of age and older, to treat and prevent flare-ups of mild to moderately active ulcerative colitis.

---

Who Should NOT Use Mesacol

Mesacol is contraindicated and should not be used by individuals with:

• A known or suspected hypersensitivity or allergy to mesalamine, aminosalicylates, or salicylates (including aspirin).
• Severe renal impairment or severe hepatic impairment.

---

Use with Caution

Caution is generally advised, and a healthcare provider should be informed about a history of or current conditions, including:

• Kidney or liver disease (pre-existing renal or hepatic impairment).
• Pyloric stenosis or any other suspected gastrointestinal obstruction.
• Blood disorders.
• A skin condition such as atopic dermatitis or eczema, as Mesacol may increase sensitivity to sunlight.
• Current use of certain other medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), azathioprine, or 6-mercaptopurine, which may increase the risk of certain side effects.

Patients should also be advised to drink plenty of fluids while taking this medication to help prevent the formation of kidney stones. Use in pregnancy and breastfeeding should be determined by a healthcare provider after carefully weighing the benefits against potential risks.

Interactions with other medicines and products

Official regulatory information for Mesalazine (Месакол) outlines specific interaction patterns that necessitate clinical monitoring or altered administration.

Documented Pharmacological Interactions

Interacting Agents	Official Regulatory Outcome
Thiopurines (Azathioprine, 6-Mercaptopurine, Thioguanine)	Co-administration increases the potential for blood dyscrasias and myelosuppression due to inhibition of Thiopurine Methyltransferase (TPMT). Regulatory guidance requires regular monitoring of blood counts.
Nephrotoxic Agents (e.g., NSAIDs)	Concurrent use may increase the risk of renal adverse reactions/nephrotoxicity. Monitoring of renal function is required, especially in patients with known renal impairment.
Coumarin-type Anticoagulants (e.g., Warfarin)	Administration may result in decreased anticoagulant activity, requiring close monitoring of Prothrombin Time.

---

Other Interactions and Constraints

Interactions Affecting Formulation Release

Preparations that lower stool pH, such as Lactulose, may prevent the delayed release of Mesalazine from the tablet, potentially reducing its local activity. Separation of administration time is generally required to mitigate this risk.

Interference with Laboratory Tests

The main Mesalazine metabolite, N-acetyl-5-aminosalicylic acid, can cause spuriously elevated test results when measuring urinary normetanephrine by liquid chromatography. Contact with Sodium Hypochlorite Bleach may also cause a red-brown discoloration of the urine.

How Месакол Works: Mechanism of Action

Месакол (Mesalazine) exerts its activity predominantly within the inflamed colonic mucosa, utilizing a local, multi-targeted pharmacodynamic mechanism.

Molecular Pathways and Targets

The drug functions as a local inhibitor of key enzymes in the Arachidonic Acid Cascade, specifically Cyclooxygenase (COX) and 5-Lipoxygenase (5-LOX). This blockade prevents the formation of pro-inflammatory lipid mediators, such as prostaglandins and leukotrienes. The resulting physiological effect is a reduction in the synthesis of mediators that regulate vascular permeability and chemotaxis.

Intracellular Signal Control

At the intracellular level, Mesalazine modulates transcription factors. It inhibits the activation of NF-κB, which reduces the production of pro-inflammatory cytokines, while simultaneously acting as an agonist for PPAR-γ, which promotes anti-inflammatory signaling. This modifies the cellular environment, contributing to a regulated inflammatory state.

Cellular Protection

The drug engages mechanisms that influence cellular stability by acting as a scavenger of free radicals and reactive oxygen species (ROS). By neutralizing these damaging agents, it reduces oxidative stress on the epithelial cells of the colon, promoting the preservation of mucosal barrier integrity and epithelial restitution.

Месакол (mesalazine) is an aminosalicylate medication available in multiple formulations to treat inflammatory bowel diseases like ulcerative colitis. Your doctor will prescribe a specific dose and formulation based on your condition's location and severity. It is crucial to follow the prescribed regimen exactly as instructed.

General Administration Guidelines

• Maintain Hydration: Drink an adequate amount of fluids while using this medication to help prevent potential kidney issues like nephrolithiasis (kidney stones).
• Do Not Stop Abruptly: Continue the treatment for the full prescribed duration, even if symptoms improve, unless your healthcare provider advises otherwise. Discontinuing treatment prematurely may increase the risk of relapse.
• Missed Dose: If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed one and continue your regular schedule. Do not take two doses at the same time to compensate for a missed dose.

Specific Formulations

Formulation	Instructions for Use
Oral Tablets/Capsules	Swallow the tablet or capsule whole with a drink of water. Do not cut, break, chew, or crush the medication, as this can affect the protective coating and alter how the medicine works. Some brands may need to be taken with food, while others require an empty stomach; always check the specific instructions for your brand.
Rectal (Suppositories/Enemas)	These are for rectal use only. Try to have a bowel movement before administration. Lie on your side and insert as far as comfortable. For best results, retain the medication for one to three hours or longer, such as by using it at bedtime.

Important Considerations

Mesalazine can sometimes cause increased sensitivity to sunlight. Patients should limit sun exposure, wear protective clothing, and use a broad-spectrum sunscreen when outdoors.

Research Evidence / Overview of Studies

Initial research focused on how the compound interacts with specific enzymes, which is believed to play a role in modulating inflammation in the intestinal lining. Studies examined the effects of the compound on markers related to pain and inflammation. Clinical research has investigated whether patient outcomes, such as inducing and maintaining remission, are improved in several areas of mild to moderate ulcerative colitis (UC).

---

Core Efficacy Studies

The primary evidence indicates that studies observed a reduction in disease activity and pain scores for patients with moderate chronic joint inflammation. Cochrane reviews and meta-analyses have affirmed the use of Mesalazine (the active ingredient) in inducing and maintaining remission in patients with extensive, left-sided, or distal UC. One major Phase III trial evaluated the drug's effect on decreasing inflammatory markers, with a recorded difference observed in the active group. Studies assessed the timeline of observed changes in patient status. Research also examined long-term tolerability, including comparative assessments against other tested compounds. For distal disease, the use of rectal formulations, sometimes in combination with oral forms, has been explored, with studies evaluating whether this approach is associated with improvements in disease outcomes like mucosal healing.

---

Studies in Specific Populations

Research has evaluated the compound's tolerability in elderly populations. Studies have also examined the drug's effect in pediatric cases (children aged 5 and older). Preliminary data from trials in this younger population indicates a finding, but more research is necessary before any definitive conclusions can be drawn about the compound's use in all pediatric cases. Studies have also explored the use of this treatment in people with specific conditions, such as those with severe kidney disease, noting that caution is generally required.

Common questions about Azithromycin (FAQ)

---

Q: What is the best way to take Azithromycin?

Azithromycin can typically be taken with or without food. The specific instructions may vary slightly based on the form of the medication (tablet, capsule, or liquid suspension).

For the extended-release liquid, regulatory information indicates it must be taken on an empty stomach, which means at least one hour before eating or two hours after a meal. Patients are generally advised to follow the specific instructions provided by their pharmacist or healthcare professional. Adhering closely to the prescribed dosing schedule supports the medication's intended effect.

---

Q: Can I stop taking Azithromycin as soon as I feel better?

The common regulatory recommendation is to complete the entire course of Azithromycin as prescribed. Stopping treatment early, even if symptoms improve, may allow the infection to return and is a factor contributing to the development of antibiotic resistance. Antibiotics like Azithromycin are prescribed for a specific duration to help ensure the complete elimination of the target bacteria. It is important to adhere to the full dosing regimen.

---

Q: What should I do if I miss a dose?

If a dose is missed, the general recommendation is to take it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed one is typically skipped, and the regular schedule is continued. It is advised not to take two doses at the same time to compensate for a missed dose. Questions or concerns about missed doses should be directed to a healthcare provider or pharmacist for guidance.

---

Q: Does Azithromycin interact with alcohol?

While there are no specific warnings on the official product label that state Azithromycin and alcohol must be strictly avoided, many healthcare professionals suggest avoiding or limiting alcohol intake while being treated for an infection. Alcohol may potentially affect the body's immune response, which could slow recovery. Also, both Azithromycin and alcohol have the potential to cause side effects such as nausea or dizziness, and combining them may potentially increase the risk of these effects.

---

Q: Can Azithromycin be used to treat viral infections like the common cold or flu?

No, Azithromycin is an antibiotic specifically indicated for the treatment of bacterial infections only. It is not effective against viruses, including those that cause the common cold or flu. Using an antibiotic when not needed carries a known risk and is a factor in the development of antibiotic-resistant bacteria. Azithromycin is intended only for treatment of specific bacterial infections as prescribed by a licensed healthcare professional.

How to Store and Dispose of Месакол?

The storage and disposal of Месакол (Mesalazine enteric-coated tablets) must strictly follow the official instructions provided on the regulatory label to maintain the drug’s stability and effectiveness.

---

Official Storage Requirements

Condition	Requirement	Implication
Temperature	Store below 30 C	Avoid excessive heat or freezing.
Moisture/Light	Store in the original package	Mandatory protection from moisture.
Container	Keep container closed tightly	Preserves the stability and shelf-life.

---

Disposal Instructions

Official regulatory guidelines state that there are no special requirements for the disposal of unused or expired Месакол tablets. The product is not classified as hazardous medicinal waste. Disposal should generally follow local pharmaceutical waste rules to ensure safe removal from the household environment.